Editorial Comment on "A Comparison Between Intravesical Gemcitabine Plus Docetaxel and Intravesical Bacillus Calmette-Guérin in the Treatment of Nonmuscle Invasive Naive Urinary Bladder Cancer: A Systematic Review and Meta-analysis of Oncological Outcomes".

Saved in:
Bibliographic Details
Title: Editorial Comment on "A Comparison Between Intravesical Gemcitabine Plus Docetaxel and Intravesical Bacillus Calmette-Guérin in the Treatment of Nonmuscle Invasive Naive Urinary Bladder Cancer: A Systematic Review and Meta-analysis of Oncological Outcomes".
Authors: Michael PD; Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, OH., Campbell RA; Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, OH. Electronic address: campber7@ccf.org.
Source: Urology [Urology] 2025 May; Vol. 199, pp. 179-180. Date of Electronic Publication: 2025 Feb 10.
Publication Type: Journal Article; Comment
Journal Info: Publisher: Elsevier Science Country of Publication: United States NLM ID: 0366151 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-9995 (Electronic) Linking ISSN: 00904295 NLM ISO Abbreviation: Urology Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1527-9995
DOI:10.1016/j.urology.2025.02.001